Linn H. Steffensen

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

Journal: The New England journal of medicine

Published: July 01, 2026

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Intrathecal Mesenchymal Stem Cells in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial (SMART-MS).

Journal: Neurology

Published: May 04, 2026

Prehospital thrombolytic treatment of acute ischemic stroke using a remotely controlled CT scanner.

Prehospital thrombolytic treatment of acute ischemic stroke using a remotely controlled CT scanner.

Journal: Scientific reports

Published: July 07, 2025

Geographical differences in thrombolysis treatment for acute ischaemic stroke.

Geographical differences in thrombolysis treatment for acute ischaemic stroke.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: December 18, 2024

Correction: Geographical differences in thrombolysis treatment for acute ischaemic stroke

Correction: Geographical differences in thrombolysis treatment for acute ischaemic stroke

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: December 18, 2024

Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study.

Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study.

Journal: Journal of neurology

Published: March 04, 2023

Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation.

Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation.

Journal: BMC neurology

Published: December 14, 2022

Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.

Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.

Journal: European journal of neurology

Published: November 10, 2022

Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results.

Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results.

Journal: European stroke journal

Published: June 26, 2022

Tenofovir as a treatment option for multiple sclerosis.

Tenofovir as a treatment option for multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: July 26, 2020

Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design.

Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design.

Journal: European stroke journal

Published: December 01, 2018

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Journal: Acta neurologica Scandinavica

Published: August 04, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026